BSE · 530119
Natraj Proteins Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹118 Cr with net profit ₹-1 Cr — a -1.24% net margin, versus -6.45% the period before.
Shareholding
As of 2026-06-30
- Promoter41.82%
- Public56.28%
- DII1.9%
3,099 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.71× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Solvent Extraction · ranked #21 of 30 by market cap · medians across 26 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Marico Limited | ₹1,14,953 Cr | 65.63 | 27.31 | 41.85% | 12.95% |
| Patanjali Foods Limited | ₹38,775 Cr | 19.26 | 2.96 | 15.37% | 4.52% |
| AWL Agri Business Limited | ₹24,379 Cr | 83 | 2.32 | 9.98% | 1.39% |
| Gokul Agro Resources Ltd. | ₹6,644 Cr | 55.87 | 2.33 | 25.96% | 1.53% |
| CIAN Agro Industries & Infrastructure Ltd. | ₹4,005 Cr | 17.98 | 1.89 | 10.34% | 10.05% |
| Avt Natural Products Ltd. | ₹1,072 Cr | 48.57 | 1.92 | 11.59% | 9.09% |
| Shri Venkatesh Refineries Ltd. | ₹905 Cr | 23.68 | 7.68 | 29.06% | 2.49% |
| Modi Naturals Limited | ₹529 Cr | 11.91 | 3.07 | 29.21% | 6.99% |
| KN Agri Resources Limited | ₹512 Cr | 16.17 | 1.33 | 8.23% | 1.75% |
| Kriti Nutrients Limited | ₹362 Cr | 10.85 | 1.58 | 14.8% | 3.68% |
| Natraj Proteins Ltd.(this company) | ₹13 Cr | 11.75 | 0.4 | 3.4% | 1.13% |
AI analysis
AI-generated · google/gemini-2.5-flashNatraj Proteins Ltd. is listed with a market capitalization of Rs 14 Cr. The company has a PE ratio of 12.67 and a book value of Rs 88.91. Its EPS stands at Rs 3.03.
Positives
- +The Return on Equity (ROE) is high at 340.49%.
- +Promoter pledging is 0%, indicating no shares are pledged.
- +The profit margin is high at 112.74%.
Negatives
- −Revenue decreased from Rs 194.03 Cr in March 2024 to Rs 118.27 Cr in March 2025.
- −Net profit has been negative in the last two annual periods, with -Rs 12.52 Cr in March 2024 and -Rs 1.46 Cr in March 2025.
- −The company reported negative EPS of -Rs 3.90 in March 2025 and -Rs 33.41 in March 2024.
- −Promoter shareholding at 41.82% is below 50% as of June 30, 2026.
- −Revenue in the latest quarter (Mar 2026) was Rs 18.87 Cr, which is lower than the Rs 33.41 Cr in Dec 2024.
Financial Performance
In the fiscal year ending March 2025, Natraj Proteins Ltd. reported revenue of Rs 118.27 Cr. This represents a decrease from the Rs 194.03 Cr reported in March 2024. The company's net profit for March 2025 was -Rs 1.46 Cr, following a net loss of -Rs 12.52 Cr in March 2024. Over the last three annual periods, net profit has fluctuated significantly, from Rs 9.36 Cr in March 2022 to -Rs 1.46 Cr in March 2025.
Profitability & Returns
Natraj Proteins Ltd. has reported a profit margin of 112.74%. The Return on Equity (ROE) is 340.49%, while the Return on Capital Employed (ROCE) is 5.03%. The company's EPS was Rs 3.03, though it reported negative EPS figures in the last two annual periods: -Rs 33.41 in March 2024 and -Rs 3.90 in March 2025.
Balance Sheet
The company's debt-to-equity ratio is 0.95. The book value per share is Rs 88.91. Natraj Proteins Ltd. does not have any reported dividend yield.
Ownership & Pledges
There are no reported pledged shares by the promoters. The number of shareholders as of June 30, 2026, was 3099.
Data as of — price: 2026-07-30 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.